Gland Pharma spurts 5% in early trade on robust Q4 results; net profit rises 34% yoy to Rs260.4cr

The companys revenue jumps 40% yoy to Rs887.7cr. It maintained a healthy EBITDA margin of 40% and PAT margin of 28% during the quarter.

from India Infoline News Service https://ift.tt/3yj508j